What is circulating tumor DNA (ctDNA) testing
Circulating Tumor DNA (ctDNA) Testing: An Educational Overview
What Is ctDNA?
Circulating tumor DNA (ctDNA) is DNA that comes from cancer cells and circulates freely in your bloodstream. When cancer cells die or break apart, they release fragments of their DNA into the blood. ctDNA testing detects and analyzes these tiny pieces of cancer DNA in a simple blood draw—sometimes called a "liquid biopsy."
Think of it this way: instead of taking a tissue sample directly from a tumor (traditional biopsy), doctors can now detect cancer-related genetic information through a blood test.
How Does ctDNA Testing Work?
- Blood sample collection - A standard blood draw, similar to routine lab work
- Laboratory analysis - Specialized equipment detects and sequences the tumor DNA fragments
- Genetic analysis - The lab identifies specific mutations or changes in the DNA that match the patient's cancer
- Results reporting - Information about tumor burden, specific mutations, and treatment response
Clinical Uses of ctDNA Testing
Detection and Monitoring:
- Detecting cancer recurrence earlier than imaging tests might show it
- Monitoring treatment response by tracking whether ctDNA levels are decreasing
- Assessing minimal residual disease (MRD)—whether any cancer cells remain after treatment
Treatment Planning:
- Identifying specific mutations that might respond to targeted therapies
- Helping doctors understand which treatments might be most effective for your specific cancer
Prognosis Assessment:
- Higher ctDNA levels may indicate more active disease
- Declining ctDNA levels often suggest treatment is working
Current Clinical Applications
According to NCCN Guidelines and ASCO recommendations, ctDNA testing is increasingly being integrated into cancer care, particularly for:
- Colorectal cancer monitoring
- Breast cancer recurrence detection
- Lung cancer surveillance
- Other solid tumors where specific mutations can be tracked
The American Cancer Society notes that while ctDNA testing shows promise, it's still evolving, and its role varies depending on cancer type and clinical situation.
Important Context
ctDNA testing is a tool to inform care, not a replacement for:
- Physical exams
- Imaging studies (CT scans, PET scans, etc.)
- Tissue biopsies when needed
- Your doctor's clinical judgment
The presence or absence of ctDNA must be interpreted within your complete clinical picture—your symptoms, imaging results, and overall health status all matter.
Questions to Ask Your Oncologist
If ctDNA testing is being considered for you:
- "Is ctDNA testing appropriate for my type of cancer?"
- "How will the results change my treatment plan?"
- "How often would I need this test?"
- "What do the results mean if ctDNA is detected? If it's not detected?"
- "Are there any limitations or false positives I should know about?"
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated May 19, 2026. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about General
- What somatic and germline testing is recommended for me
- What are tumor markers and how reliable are they
- Regarding non-UV virus-positive MCC MRD, ctDNA
- Should I get ctDNA monitoring after treatment to detect early recurrence
- What is minimal residual disease (MRD) testing
- What are genomic sequencing, genetic testing, and biomarker testing
- How can you treat neuroendocrine cancers like carcinoid tumors
- Tumor shean with tmz possiblel